Rottneros annonserar joint venture med Arctic Paper i Polen Rottneros och Arctic Paper har beslutat ...
Accelererande organiskt tillväxt... Efterfrågan ökade tydligt för merparten av Midways bolag i Q4.
Redeye retains its positive view on Sdiptech following a slightly stronger Q4 report than expected.
Redeye retains its positive view on Bredband2 following a Q4 report largely in line with our forecas...
Raute’s Q4 report didn’t provide that many news as recent profitability challenges are familiar.
Mangold uppdaterar läkemedelsutvecklaren Double Bond Pharma (DBP).
Cibus will report its Q4 results on 24 February. We expect net operating income (NOI) of EUR 20.
EAB reported H2 comparable operating income of EUR 11.
Q4 was clearly hit by Covid-19, but we expect things to improve over the coming quarters (although Q...
Redeye comments on today’s updated schedule for Orphazyme’s planned NDA resubmission with arimoclomo...
Redeye comments on GiG’s extended contract with Betsson which now runs to Q4 25 which lowers risk an...
Redeye is encouraged to see another surprisingly strong quarter with sales beating our expectations ...
Redeye states that the partnership with MaxLinear further strengthens Sivers’ footprint through its ...
Redeye comments on Alligator Bioscience’s end-of-year report.
Redeye provides its initial comments on the report ahead of a more detailed update discussing the ca...
Redeye comments on Impact Coatings Q4 report which only included minor deviations from our forecasts...
Redeye is encouraged to see another quarter of solid improvement.
Rovio’s Q4 report offered a 7% beat on revenue and 35% beat on adjusted EBIT relative to Infront con...
Redeye recognizes Bambuser's high sequential growth rates in Q4, which align with expectations.
